论文部分内容阅读
目的观察联合应用甲钴铵与灯盏细辛治疗2型糖尿病神经病变的临床疗效。方法入选2型糖尿病患者68例,随机分为两组:治疗组(38例)和对照组(30例),对照组予以甲钴铵治疗,治疗组在此基础上加用灯盏细辛,疗程均为4周。结果与对照组比较,治疗组对各种临床症状、肌肉与关节神经反射的有效率和神经传导速度(MNC和sCV)的改善均明显提高.明显高于对照组(P<0.05)。结论联合应用甲钴胺及灯盏细辛治疗2型糖尿病神经病变,临床疗效较好,无不良反应,值得临床推广应用。
Objective To observe the clinical efficacy of combination of mecobalamin and erigeron in the treatment of type 2 diabetic neuropathy. Methods Sixty-eight patients with type 2 diabetes mellitus were randomly divided into two groups: the treatment group (38 cases) and the control group (30 cases), while the control group was treated with methylcobalamin. The treatment group was given the Erigeron Breviscapus treatment, All for 4 weeks. Results Compared with the control group, the treatment group improved the efficiency of all kinds of clinical symptoms, muscle and joint reflex and the improvement of nerve conduction velocity (MNC and sCV), which was significantly higher than that of the control group (P <0.05). Conclusions Combined use of mecobalamin and erigeron are effective in treating type 2 diabetic neuropathy with good clinical efficacy and no adverse reactions, which is worthy of clinical application.